Johnson & Johnson
JNJ
#23
Rank
A$794.32 B
Marketcap
A$329.97
Share price
2.02%
Change (1 day)
39.19%
Change (1 year)

Johnson & Johnson is a global American pharmaceutical and consumer goods company with headquarters in New Brunswick, New Jersey. The company is listed in the Dow Jones Industrial Average.

EPS for Johnson & Johnson (JNJ)

EPS in 2026 (TTM): A$13.04

According to Johnson & Johnson's latest financial reports the company's current EPS (TTM) is A$12.38. In 2025 the company made an earnings per share (EPS) of A$15.79 an increase over its 2024 EPS that were of A$9.49.

EPS history for Johnson & Johnson from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A$13.04-17.39%
2025A$15.7966.46%
2024A$9.49-53.6%
2023A$20.44111.16%
2022A$9.68-13.84%
2021A$11.2441.81%
2020A$7.92-18.92%
2019A$9.7721.2%
2018A$8.061125.3%
2017A$0.66-92.23%
2016A$8.477.37%
2015A$7.89-4.16%
2014A$8.2318.1%
2013A$6.9724.88%
2012A$5.58

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
A$9.95-19.65%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$1.86-85.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
A$5.12-58.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
A$5.09-58.91%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Eli Lilly
LLY
A$40.01 223.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$3.63-70.70%๐Ÿ‡ซ๐Ÿ‡ท France
Gilead Sciences
GILD
A$9.71-21.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Stryker Corporation
SYK
A$12.04-2.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$5.04-59.28%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$5.51-55.52%๐Ÿ‡ฌ๐Ÿ‡ง UK